Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT

MeSH terms

• Adolescent
• Adult
• Aged
• Bone Marrow Transplantation / adverse effects*
• Bone Marrow Transplantation / methods*
• Female
• Graft vs Host Disease / etiology*
• Graft vs Host Disease / prevention & control*
• Humans
• Immunosuppressive Agents / administration & dosage*
• Male
• Methotrexate / administration & dosage*
• Middle Aged
• Retrospective Studies
• Risk Factors
• Tacrolimus / administration & dosage*
• Young Adult